September 21, 2023
CaaMTech Collaboration Investigates Terpene Production in Magic Mushrooms
Genomic sequences of various Psilocybe species revealed an unexpected wealth of genes encoding sesquiterpene synthases
Updates
September 14, 2023
CaaMTech CEO to Present at ACS Meeting
The American Chemical Society will host the Chemistry of Psychedelics symposium at the 2023 Rocky Mountain Regional Meeting Sept. 14–17 the University of Wyoming
September 12, 2023
CaaMTech Crystallography Collaboration Clarifies Chemical Characterization Confusion
The publication of the crystal structure of 4-AcO-EPT fumarate fumaric acid also exemplifies CaaMTech’s pioneering tryptamine prodrug and SAR research
August 4, 2023
CaaMTech and University of Massachusetts Dartmouth Collaborate to Research N-Cyclohexyltryptamine Structures
Dialkyl tryptamines have received widespread attention for their potential to treat numerous mood disorders. But secondary tryptamines, or monoalkyl tryptamines, have received almost no such attention.
March 28, 2023
Foundational Science for the Psilocybin Analog 4-PrO-DMT in Mice
4-Pro-DMT is a synthetic psilocybin analog and purported prodrug of psilocin
March 14, 2023
CaaMTech Synthesizes and Characterizes Monoalkyl Tryptamine 4-HO-NiPT
4-HO-NiPT is an active metabolite of 4-HO-DiPT and closely related to norpsilocin
November 15, 2022
Psilacetin is More Potent than Psilocybin, Study Shows
Researchers directly compared psilocybin with understudied magic mushroom molecules, and synthetic analogs such as psilacetin
September 22, 2022
CaaMTech Creates Two New Prodrugs of 4-HO-DiPT
4-HO-DiPT has been proposed as a more clinically-optimized alternative to psilocybin
September 14, 2022
CaaMTech Publishes Fundamental Research on Aeruginascin Derivatives
Aeruginascin is a naturally-occurring quaternary tryptammonium compound found in Magic Mushrooms
July 6, 2022
CaaMTech Collaborates with the Alexander Shulgin Research Institute to Study Shulgin Compounds
CaaMTech will help carry on Dr. Alexander Shulgin’s legacy by developing ASRI’s novel compounds
